Compare Abeona Therapeutics Inc (ABEO) vs Zoom Video Communications, Inc. (ZM) Price & Performance

ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.

Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.

Zoom Communications (ZM) trades at $85.68, down 1.68% on the day, with a bearish technical outlook despite strong fundamentals. The stock shows robust profitability with 77.4% gross margins and 42% net income margin, while trading at attractive valuation multiples (P/E 12.5x, P/S 5.2x). Recent Q1 2026 earnings beat expectations, and the company continues AI-driven growth through acquisitions like Common Room and new product launches.

ZM presents a compelling value opportunity with significant upside to the $118.79 consensus price target, though technical weakness and competitive pressures from Microsoft and Google remain headwinds. The company's strong cash position ($7.7B) and strategic Anthropic investment provide additional upside catalysts, making it attractive for patient investors despite near-term bearish technical signals.